-
1
-
-
84873635562
-
-
Cubicin (daptomycin for injection) [package insert] Lexington MA: Cubist Pharmaceuticals
-
Cubicin (daptomycin for injection) [package insert]. Lexington, MA: Cubist Pharmaceuticals.
-
-
-
-
3
-
-
40349100430
-
Daptomycin use in infants: Report of two cases with peak and trough drug concentrations
-
Cohen-Wolkowiez M, Smith PB, Benjamin DK Jr, Fowler VG Jr, Wade KC. Daptomycin use in infants: report of two cases with peak and trough drug concentrations. J Perinatol 2008; 28: 233-234.
-
(2008)
J Perinatol
, vol.28
, pp. 233-234
-
-
Cohen-Wolkowiez, M.1
Smith, P.B.2
Benjamin Jr., D.K.3
Fowler Jr., V.G.4
Wade, K.C.5
-
4
-
-
77952936197
-
Daptomycin use in a neonate: Serum level monitoring and outcome
-
Sarafidis K, Iosifidis E, Gikas E, Tsivitanidou M, Drossou-Agakidou V, Roilides E. Daptomycin use in a neonate: serum level monitoring and outcome. Am J Perinatol 2010; 27: 421-424.
-
(2010)
Am J Perinatol
, vol.27
, pp. 421-424
-
-
Sarafidis, K.1
Iosifidis, E.2
Gikas, E.3
Tsivitanidou, M.4
Drossou-Agakidou, V.5
Roilides, E.6
-
5
-
-
79951932614
-
Successful treatment of meticillin-resistant Staphylococcus aureus bacte-raemia in a neonate using daptomycin
-
Hussain A, Kairamkonda V, Jenkins DR. Successful treatment of meticillin-resistant Staphylococcus aureus bacte-raemia in a neonate using daptomycin. J Med Microbiol 2011; 60: 381-383.
-
(2011)
J Med Microbiol
, vol.60
, pp. 381-383
-
-
Hussain, A.1
Kairamkonda, V.2
Jenkins, D.R.3
-
6
-
-
84873627124
-
Pharmacokinetics of daptomycin in pediatric patients
-
Toronto 2007 May 5-8; Toronto, Canada 2007
-
Kearns GL, Jacobs RF, Jafri HS, Hong EF, Benziger DP. Pharmacokinetics of daptomycin in pediatric patients. 2007 Pediatric Academic Societies'Annual Meeting, Toronto 2007 May 5-8; Toronto, Canada 2007.
-
2007 Pediatric Academic societies'Annual Meeting
-
-
Kearns, G.L.1
Jacobs, R.F.2
Jafri, H.S.3
Hong, E.F.4
Benziger, D.P.5
-
7
-
-
77956146862
-
Staphylococcus aureus: A continuously evolving and formidable pathogen in the neonatal intensive care unit
-
Carey AJ, Long SS. Staphylococcus aureus: a continuously evolving and formidable pathogen in the neonatal intensive care unit. Clin Perinatol 2010; 37: 535-546.
-
(2010)
Clin Perinatol
, vol.37
, pp. 535-546
-
-
Carey, A.J.1
Long, S.S.2
-
8
-
-
84969254848
-
Performance standards for antimicrobial susceptibility testing. CLSI approved standard M100-S17
-
CLSI Wayne, PA
-
CLSI. 2007. Performance standards for antimicrobial susceptibility testing. CLSI approved standard M100-S17. Clinical and Laboratory Standards Institute, Wayne, PA.
-
(2007)
Clinical and Laboratory Standards Institute
-
-
-
9
-
-
13944274479
-
Methicillin-resistant Staphylococcus aureus: An evolutionary, epidemiologic, and therapeutic odyssey
-
Deresinski S. Methicillin-resistant Staphylococcus aureus: an evolutionary, epidemiologic, and therapeutic odyssey. Clin Infect Dis 2005 15; 40: 562-573.
-
(2005)
Clin Infect Dis
, vol.15
, Issue.40
, pp. 562-573
-
-
Deresinski, S.1
-
10
-
-
0037006653
-
Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal ne-crotising pneumonia in young immunocompetent patients
-
Gillet Y, Issartel B, Vanhems P, Fournet JC, Lina G, Bes M, Vandenesch F, Piémont Y, Brousse N, Floret D, Etienne J. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal ne-crotising pneumonia in young immunocompetent patients. Lancet 2002; 359: 753-759.
-
(2002)
Lancet
, vol.359
, pp. 753-759
-
-
Gillet, Y.1
Issartel, B.2
Vanhems, P.3
Fournet, J.C.4
Lina, G.5
Bes, M.6
Vandenesch, F.7
Piémont, Y.8
Brousse, N.9
Floret, D.10
Etienne, J.11
-
11
-
-
79951821210
-
Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: Executive summary
-
Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gor-witz RJ, Kaplan SL, Karchmer AW, Levine DP, Murray BE, J Rybak M, Talan DA, Chambers HF. Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis 2011; 52: 285-292.
-
(2011)
Clin Infect Dis
, vol.52
, pp. 285-292
-
-
Liu, C.1
Bayer, A.2
Cosgrove, S.E.3
Daum, R.S.4
Fridkin, S.K.5
Gor-Witz, R.J.6
Kaplan, S.L.7
Karchmer, A.W.8
Levine, D.P.9
Murray, B.E.10
Rybak M, J.11
Talan, D.A.12
Chambers, H.F.13
|